Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-14

Clinical Trial Update: Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Bawei Shenqi Pill in ankylosing spondylitis, currently in Phase 2/Phase 3 with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bawei Shenqi Pill

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Ankylosing Spondylitis | Phase 2, Phase 3 | Status: UNKNOWN